ARCHIVES

Ethicists dispute von Eschenbach’s claim that his NCI-FDA conflicts are managed. NCI-FDA chief appears to cite Klausner-era “in-box rule.”

This article is from The Cancer Letter archive.

Vol. 31 No. 46 | December 16, 2005

Download PDF Visit The Full Archive

Related Articles

Alternative Medicine Officer Awards 30 Research Grants

October 15, 1993

In Brief: Money Buys Progress In Cancer Research, DeVita says; John Montgomery To Give Clowes Lecture

April 29, 1983

Hong Succeeds Curran As AACR President, Horwitz Is President-Elect; 5 New Directors.

March 30, 2001

(8-page issue)

October 4, 2002

NIH Proposes Stricter Rules On Extramural Research Financial Conflicts

May 21, 2010

Women’s Health: Treatment to Move Toward Pre-Cancer, Klausner Says

December 5, 1997